CSF1R and neoplasm: Targeting multiple kinases to simultaneously block VEGFR-, FGFR-, and CSF-1R-mediated pathways may be a more effective method of preventing tumor angiogenesis and tumor immune evasion, representing an attractive anti-cancer therapy approach [51,52,53,54].